iShares 3 7 Year Treasury Bond ETF vs Lemonade Inc — how do they compare? iShares 3 7 Year Treasury Bond ETF trades at $113.49 (market cap $16.72B), while Lemonade Inc trades at $46.46 (market cap $3.63B). The key difference: iShares 3 7 Year Treasury Bond ETF is far larger — about 4.6× Lemonade Inc's market cap, and iShares 3 7 Year Treasury Bond ETF is more actively traded (3,963,319 versus 1,544,794). Which is the better fit depends on your goals — on Pluang, investors hold iShares 3 7 Year Treasury Bond ETF for 43 Days and Lemonade Inc for 27 Days on average.
| IEI | LMND | |
|---|---|---|
Market Cap | $16.72B | $3.63B |
Volume | 3,963,319 | 1,544,794 |
Sector | Fixed Income | Financials |
52-Week High | $120.72 | $96.57 |
52-Week Low | $113.17 | $43.91 |
Typical Hold Time | 43 Days | 27 Days |
Enterprise Value | — | $3.49B |
Signals from Pluang's Aura AI — not financial advice
IEI trades at $113.57 with minimal daily movement (+0.17%), showing stability amid broader market volatility. The technical picture remains bearish with moving averages signaling downward pressure, though oscillators suggest neutral momentum. Recent dividend payments of $0.37-0.38 per share demonstrate consistent shareholder returns. The stock faces headwinds from rising Treasury yields and bond market volatility, which could impact investor appetite for equities.
Outlook remains cautious as higher interest rates and bond market turbulence create challenging conditions. The bearish technical signals and neutral fundamental metrics suggest limited near-term upside potential. Key risks include continued bond market volatility and macroeconomic pressures, though consistent dividend payments provide some defensive characteristics for income-focused investors.
Lemonade (LMND) trades at $46.91, up 0.17% on the day, with a bearish technical signal driven by moving averages. The company shows strong revenue growth, with 2025 revenue reaching $738 million, and net losses narrowing to -$166 million. Recent news highlights expansion into new states and AI-driven efficiency gains, with management targeting EBITDA profitability by late 2026.
The outlook is mixed: growth and margin improvement offer upside, but persistent losses and high valuation multiples pose risks. Analysts are divided with a consensus price target of $67, suggesting potential upside if profitability targets are met. Key risks include execution on profitability and competitive pressures in the insurtech space.
Trailing returns across standard periods
Latest headlines on both assets
IEI tracks the ICE U.S. Treasury 3-7 Year Bond Index, offering exposure to intermediate-term government debt. It serves as a conservative middle ground in the Treasury yield curve, providing higher yields than short-term bills with less volatility than long-term bonds.
Read more on IEI →Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →